A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia
Clinical trial NCT00888693 · COMPLETED
Trial details
- NCT number
- NCT00888693
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.